AU2002250057A1 - New crystal forms of oxcarbazepine and processes for their preparation - Google Patents

New crystal forms of oxcarbazepine and processes for their preparation

Info

Publication number
AU2002250057A1
AU2002250057A1 AU2002250057A AU2002250057A AU2002250057A1 AU 2002250057 A1 AU2002250057 A1 AU 2002250057A1 AU 2002250057 A AU2002250057 A AU 2002250057A AU 2002250057 A AU2002250057 A AU 2002250057A AU 2002250057 A1 AU2002250057 A1 AU 2002250057A1
Authority
AU
Australia
Prior art keywords
oxcarbazepine
processes
preparation
crystal forms
new crystal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002250057A
Other languages
English (en)
Inventor
Judith Aronhime
Yana Berkovich
Ben-Zion Dolitzky
Nissim Garth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of AU2002250057A1 publication Critical patent/AU2002250057A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2002250057A 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation Abandoned AU2002250057A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12
US60/268,314 2001-02-12
PCT/US2002/004065 WO2002064557A2 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Publications (1)

Publication Number Publication Date
AU2002250057A1 true AU2002250057A1 (en) 2002-08-28

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002250057A Abandoned AU2002250057A1 (en) 2001-02-12 2002-02-12 New crystal forms of oxcarbazepine and processes for their preparation

Country Status (11)

Country Link
US (1) US7183272B2 (https=)
EP (1) EP1368322A4 (https=)
JP (1) JP2004526706A (https=)
AU (1) AU2002250057A1 (https=)
CA (1) CA2437402A1 (https=)
DE (1) DE02718948T1 (https=)
ES (1) ES2211373T1 (https=)
HU (1) HUP0303154A3 (https=)
IL (1) IL157351A0 (https=)
TR (1) TR200400313T3 (https=)
WO (1) WO2002064557A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091339B2 (en) 2002-06-14 2006-08-15 Taro Pharmaceuticals Usa, Inc. Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
US7563930B2 (en) * 2005-11-22 2009-07-21 Teva Pharmaceutical Industries Ltd Crystal forms of Cinacalcet HCI and processes for their preparation
EP2662374A1 (en) * 2006-04-05 2013-11-13 OPKO Health, Inc. Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
CN102573475B (zh) * 2009-08-14 2016-01-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
BR112021005955A2 (pt) 2018-09-28 2021-07-27 Griffith University agentes e métodos para modular atividade de patógeno

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) * 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
US7091339B2 (en) 2002-06-14 2006-08-15 Taro Pharmaceuticals Usa, Inc. Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide

Also Published As

Publication number Publication date
DE02718948T1 (de) 2004-07-08
TR200400313T3 (tr) 2004-04-21
EP1368322A2 (en) 2003-12-10
HUP0303154A3 (en) 2009-08-28
WO2002064557A3 (en) 2002-10-24
ES2211373T1 (es) 2004-07-16
US20030004154A1 (en) 2003-01-02
IL157351A0 (en) 2004-02-19
US7183272B2 (en) 2007-02-27
CA2437402A1 (en) 2002-08-22
WO2002064557A9 (en) 2002-11-28
WO2002064557A2 (en) 2002-08-22
JP2004526706A (ja) 2004-09-02
EP1368322A4 (en) 2004-03-17
HUP0303154A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
AU2002364528A1 (en) Bio-implant and method of making the same
AU2002361563A1 (en) Anti-tombstoning structures and methods of manufacture
GB0124299D0 (en) Crystal structure of enzyme and uses thereof
AU2002330453A1 (en) Crystals of hydroxynorephedrine derivative
AU2002250057A1 (en) New crystal forms of oxcarbazepine and processes for their preparation
AU2002257271A1 (en) Liquid crystal assembly and method of making
IL157608A0 (en) New crystal forms of lamotrigine and processes for their preparations
AU2001280646A1 (en) Display and method of manufacture
AU2003256242A1 (en) Crystal forms of olanzapine and processes for their preparation
AU3775500A (en) Setting of gemstones
AU2002322445A1 (en) Crystals and structures of arnb aminotransferases
AU2001248766A1 (en) Process for preparation of sulfonamide derivatives and crystals thereof
AU2002360409A1 (en) Methods and intermediates for the synthesis of azepines
AU2002340437A1 (en) Crystals and structures of yiim proteins
AU2002348942A1 (en) Process for the preparation of tofisopam and new intermediates
AU2002365245A1 (en) Crystal structure of yqej and uses thereof
WO2003016502A9 (en) Tramdorins and methods of using tramdorins
AU2002359898A1 (en) Preparation of alpha-diimines
AU2002240556A1 (en) New crystal forms of lamotrigine and processes for their preparations
AU2002248268A1 (en) Crystal modification of olanzapine
AU2002354206A1 (en) Method of screening drug
AU2002306371A1 (en) Crystals of oligosaccharides and processes for preparation thereof
AU2002355223A1 (en) Novel crystal of arylethenesulfonamide derivative and process for producing the same
AU2001288227A1 (en) Antivesicant compounds and methods of making and using thereof
AU2002235525A1 (en) Preparation of n-methylparoxetine and related intermediate compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase